{
  "trial_id": "NCT00194610",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Women ages 18 and older",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Diagnosis of interstitial cystitis",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "Subject has severity/stage of disease: at least 12 voids/day with the presence of pelvic pain",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "Ability to follow study instructions and likely to complete all required visits.",
      "label": "unknown",
      "evidence": "unknown"
    },
    {
      "criterion": "Negative urine pregnancy test on the day of treatment prior to the administration of study medication (for females of childbearing potential; if applicable)",
      "label": "met",
      "evidence": "patient text"
    }
  ],
  "exclusion": [
    {
      "criterion": "Use of any medications that might interfere with neuromuscular function",
      "label": "unknown",
      "evidence": "unknown"
    },
    {
      "criterion": "Any medical condition that may put the subject at increased risk with exposure to Botox including diagnosed myasthenia gravis, Eaton-Lambert syndrome, amyotrophic lateral sclerosis, or any other disorder that might interfere with neuromuscular function",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "Females who are pregnant, breast-feeding, or planning a pregnancy during the study or who think that they may be pregnant at the start of the study, or females of childbearing potential who are unable or unwilling to use a reliable form of contraception during the study",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "Known allergy or sensitivity to any of the components in the study medication",
      "label": "unknown",
      "evidence": "unknown"
    },
    {
      "criterion": "Concurrent participation in another investigational drug or device study, or participation in the 30 days immediately prior to study enrollment.",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "Stress incontinence",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "Urinary tract infection at time of enrollment",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "Overtly psychotic or suicidal",
      "label": "not_met",
      "evidence": "unknown"
    }
  ],
  "notes": "Patient has a urinary tract infection and is pregnant, but is likely eligible due to the severity of her symptoms.",
  "_meta": {
    "topic_id": "51",
    "trial_id": "NCT00194610",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}